Intelligence / Healthtech / New Clinical Trials / WAKEZ HEALTH TECH ECOSYSTEM SRL
Clinicaltrial registered23 Oct 2026
WAKEZ HEALTH TECH ECOSYSTEM SRL
23 Oct 2026: Trial registered · REM Sleep Disruption and Its Potential Uses in Depression Management. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 23 Oct 2026
- Title
- REM Sleep Disruption and Its Potential Uses in Depression Management
- Conditions
- Depression / Major Depressive Disorder, Depressed Mood
- Phase
- Not applicable
- Study Type
- Interventional
- Status
- Completed
- Countries
- Romania
- Country
- Romania
- Reference
- NCT07891806
- Location
- Romania
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at WAKEZ HEALTH TECH ECOSYSTEM SRL
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Romania
New Clinical Trials
12 NovNovo Nordisk A/Strial registered · AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothClinical12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExerciseClinical12 NovPerfect Care Distributiontrial registered · Halova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal WomenClinical10 NovEli Lilly and Companytrial registered · A Study of Brenipatide in Participants With Major Depressive DisorderClinical9 NovPerfect Care Distributiontrial registered · Halova Vaginal Ovules Versus Placebo for Genitourinary Symptoms in Premenopausal WomenClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.